Skip to main navigation Skip to search Skip to main content

Study ASKB2018001: A randomized, open-labeled, historically controlled, multi-site clinical field study to assess the effectiveness and safety of three different doses of ASKB626 for the management of anemia in cats with IRIS Stage 2 or 3 CKD

Project: Research project

Project Details

Description

Study ASKB2018001: A randomized, open-labeled, historically controlled, multi-site clinical field study to assess the effectiveness and safety of three different doses of ASKB626 for the management of anemia in cats with IRIS Stage 2 or 3 CKD
StatusFinished
Effective start/end date2/1/19 → 7/30/20

Funding

  • ALCHERABIO, LLC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.